| Basic Medical Informatin |
| brand name |
| Celexa |
Razadyne, Razadyne Er, Reminyl, Nivalin |
| Treatment For |
| Depression |
Mild To Moderate Dementia Caused By Alzheimer's Disease |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| C (us) |
B (us) |
| Possible Side Effects |
| Headache With Chest Pain And Severe Dizziness, Fainting, Palpitation, Nausea, Vomiting, Diarrhea, Loss Of Appetite, Dry Mouth, Weight Loss |
Diarrhea; Dizziness; Headache; Indigestion; Loss Of Appetite; Mild Stomach Pain Or Upset; Nausea; Tiredness; Trouble Sleeping; Vomiting; Weight Loss. |
| Precautions & Contraindications |
| Seizures Or Liver, Kidney, Or Heart Disease, Qt Prolongation, Pregnancy And Breastfeeding |
Pregnant, Liver Or Kidney Problems, Heart Problems, Unexplained Fainting Episodes, Stomach Or Bowel Problems, Lung Or Breathing Problems, Copd, Or Urinary Blockage Or Trouble Urinating, Brain Lesions Or Tumors, Dementia |
| Excretion |
| Mostly As Unmetabolized Citalopram, Partly Dct And Traces Of Ddct In Urine |
Renal (95%, Of Which 32% Unchanged), Fecal (5%) |
| Storage Conditions |
| 25°c, In Airtight Container And Keep Away From Children |
Room Temperature, In An Airtight Container. Keep Away From Children |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet |
Tablet, Capsule |
| Routes (of administration) |
| Oral |
Oral |
|
Dosage |
| 20 mg |
|
| Chemical Data |
| Bioavailability |
| 80%, Peak At 4 Hours |
80-100% |
| Protein binding |
|
Hepatic, 18% |
| Metabolism |
| Hepatic |
Hepatic Partially |
| Half Life (hours) |
| 35 h |
7 h |
| Formula |
| C20h21fn2o |
C17h21no3 |
| Molecular mass (g/mol) |
| 324.392 G/mol |
287.354 G/mol |